Filter

351-360 of 374 results

  • COVID-19 Vaccination and Parental Consent

    Policy Watch

    Updated Data on State Parental Consent Laws for COVID-19 Vaccination Available Here. With the recent authorization of Pfizer’s COVID-19 vaccine for adolescents, ages 12-15, a group that totals almost 17 million, the next phase of the U.S. vaccination effort has begun. Authorization for even younger children is expected as early as the fall, and even before this point, Pfizer’s vaccine had been authorized for 16-17 year-olds. This has focused attention on the role of parents…

  • A Look at Parental Consent and COVID-19 Vaccination for Adolescents

    Feature

    Most states require parental consent at this point, though the landscape may be shifting slightly as more jurisdictions seek to encourage vaccination of young people. Parents and parental consent laws will play a critical role in the COVID-19 vaccination effort to reach children in the U.S., particularly as authorization moves to even younger ages.

  • KFF COVID-19 Vaccine Monitor: Profile Of The Unvaccinated

    Poll Finding

    This report explores the roughly a third of adults who have not received a COVID-19 vaccine and finds that, compared to vaccinated adults, they are younger, more likely to identify as Republican or Republican-leaning, with lower incomes and education levels, and more likely to be uninsured.

  • Who Remains Unvaccinated? A COVID-19 Vaccine Monitor Analysis

    News Release

    As more people across the country get at least an initial dose of a COVID-19 vaccine, public health officials are increasingly trying to reach the shrinking pool of unvaccinated adults – now roughly a third of all adults. The latest KFF COVID-19 Vaccine Monitor report explores this group’s demographic profile and finds that, compared to vaccinated adults, unvaccinated adults are younger and more likely to identify as Republican or Republican-leaning. They also have lower levels…

  • Policy Considerations as Children Ages 5-11 Become Eligible for the COVID-19 Vaccine

    News Release

    A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children. A final FDA decision, and Centers for Disease Control and Prevention actions, will follow as soon as the first week in November. As the Biden administration plans…

  • Mixed Prospects for Vaccinating Children

    From Drew Altman

    In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.